Download PDF
Thromb Haemost 1997; 77(01): 044-047
DOI: 10.1055/s-0038-1655904
Clinical Studies
Schattauer GmbH Stuttgart

Ongoing Prothrombotic State in the Portal Circulation of Cirrhotic Patients

Francesco Violi
1   The Istituto I Clinica Medico, Università “La Sapienza”, Rome, Italy
,
Domenico Ferro
1   The Istituto I Clinica Medico, Università “La Sapienza”, Rome, Italy
,
Stefania Basili
1   The Istituto I Clinica Medico, Università “La Sapienza”, Rome, Italy
,
Raffaella Lionetti
2   The II Cattedra di Gastroenterologia, Università “La Sapienza”, Rome, Italy
,
Elisabetta Rossi
1   The Istituto I Clinica Medico, Università “La Sapienza”, Rome, Italy
,
Manuela Merli
2   The II Cattedra di Gastroenterologia, Università “La Sapienza”, Rome, Italy
,
Oliviero Riggio
2   The II Cattedra di Gastroenterologia, Università “La Sapienza”, Rome, Italy
,
Mario Bezzi
3   Istituto di Radiologia, Università “La Sapienza”, Rome, Italy
,
Livio Capocaccia
2   The II Cattedra di Gastroenterologia, Università “La Sapienza”, Rome, Italy
› Author Affiliations
Further Information

Publication History

Received 25 July 1996

Accepted after revision 24 September 1996

Publication Date:
11 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Portal thrombosis may complicate the clinical course of cirrhosis, but the pathophysiologic mechanism is unclear. Aim of the study was to evaluate the behavior of clotting system and endotoxemia in portal vein and in peripheral circulation of 11 cirrhotic patients undergoing transjugular port-systemic shunt (TIPS).

Portal blood showed higher values of Fl+2 [Median (range): 2.5 (1.1-5.3) vs. 1.1 (0.6-2.1) nM, p <0.01], D-dimer [765 (184-1713) vs. 192 (64-813) ng/ml, p < 0.01] and endotoxemia [31 (16-47.2) vs. 13.7 (7.5-23.5) pg/ml, p <0.01] than peripheral circulation. In the portal vein, all but one sample had Fl+2 > 1.2 nM (upper limit of control values), all but one had D-dimer > 216 mg/dl (mean + 2 SD of controls) and 100% had values of endotoxemia > 9.6 pg/ml (upper limit of control values). Fibrinogen was lower in the portal circulation compared to peripheral circulation but the difference was not significant [85 (58-195) vs. 134 (75-244) mg/dl, p > 0.05].

Endotoxemia was directly correlated with Fl+2 (Rho = 0.92 p <0.006) and D-dimer (Rho = 0.93, p <0.005).

This study shows that an ongoing prothrombotic state is present in the portal circulation of cirrhotic patients and may play a pivotal role in the thrombotic episodes occurring in this clinical setting.

 

  • References

  • 1 Violi F, Leo R, Davi G, Praticò D, Iuliano L, Balsano F. Thrombocytopenia and thrombocytopathia in liver cirrhosis. Platelets 1992; 03: 233-239
    PubMedGoogle Scholar
  • 2 Violi F, Ferro D, Basili S, Quintarelli C, Saliola M, Alessandri C, Cordova C, Balsano F. Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced liver cirrhosis. Hepatology 1992; 15: 672-676
    CrossrefPubMedGoogle Scholar
  • 3 Ferro D, Quintarelli C, Saliola M, Alessandri C, Basili S, Bonavita S, Violi F. Prevalence of hyperfibrinolysis in patients with liver cirrhosis. Fibrinolysis 1993; 01: 59-62
    PubMedGoogle Scholar
  • 4 Violi F, Ferro D, Basili S, Quintarelli C, Musca A, Cordova C, Balsano F. CALC Group. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. Hepatology 1993; 17: 78-83
    CrossrefPubMedGoogle Scholar
  • 5 Violi F, Ferro D, Basili S, Saliola M, Quintarelli C, Alessandri C, Cordova C. Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology 1995; 109: 531-539
    CrossrefPubMedGoogle Scholar
  • 6 Oka K, Tanaka K. Intravascular coagulation in autopsy cases with liver disease. Thromb Haemost 1979; 42: 564-570
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Belli L, Romani F, Sansalone CV, Aseni P, Rondinara G. Portal thrombosis in cirrhotics. A retrospective analyses. Ann Surg 1986; 203: 286-291
    CrossrefPubMedGoogle Scholar
  • 8 Witte CL, Brewer ML, Witte MH, Pond GB. Protean manifestations of pylethrombosis. A review of thirty-four patients. Ann Surg 1985; 202: 191-202
    CrossrefPubMedGoogle Scholar
  • 9 Violi F, Ferro D, Basili S, D’Angelo A, Mazzola G, Quintarelli C, Cordova C. Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver. Br Med J 1994; 309: 239-240
    CrossrefPubMedGoogle Scholar
  • 10 Violi F, Ferro D, Basili S, Levrero M, Cordova C. Venous thrombosis in hepatitis C virus liver cirrhosis. J Invest Med 1996; 43: 550-554
    PubMedGoogle Scholar
  • 11 Guamer C, Soriano C, Tomas A, Bulbena O, Novella MT, Balanzo J, Vilardell F, Movrelle M, Moncada S. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993; 18: 1139-1143
    CrossrefPubMedGoogle Scholar
  • 12 Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral blood in patients with cirrhosis. Hepatology 1988; 08: 232-236
    CrossrefPubMedGoogle Scholar
  • 13 Van Deventer SJH, Buller HR, Ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in human: analysis of cytokine release and coagulation fibrinolytic and complement pathways. Blood 1990; 12: 2520-2526
    PubMedGoogle Scholar
  • 14 Pugh RNH, Murray-Lyon IM, Dawson JL. Transection of oesophagus for bleeding oesophagus varices. Br J Surg 1973; 60: 646-649
    CrossrefPubMedGoogle Scholar
  • 15 Rössle M, Haag K, Ochs A, Sellinger M, Nöldge G, Peramau JM, Berger E, Blum V, Gabelmann A, Havenstein KH, Langer M, Gerok W. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330: 165-171
    CrossrefPubMedGoogle Scholar
  • 16 Ochs A, Rössle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, Langer M, Blum HE. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192-1197
    CrossrefPubMedGoogle Scholar
  • 17 Pelzer H, Schwartz W. Determination of human prothrombin activation fragment Fl+2 in plasma with antibody against a synthetic peptide. Thromb Haemost 1991; 65: 153-159
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Armitage P, Berry G. Statistical methods in medical research. 02. nd ed Blackwell scientific Publication; Oxford (UK): 1990: 200-215
    Google Scholar
  • 19 Bauer KA, Rosemberg RD. The pathogenesis of the prethrombotic state in humans: insights from studies using markers of hemostatic system activation. Blood 1987; 70: 343-350
    PubMedGoogle Scholar
  • 20 Ravin HA, Rowey D, Senkins C, Fine J. On the observation of bacterial endotoxin from the gastrointestinal tract of the normal and shocked animal. J Exp Med 1960; 112: 783-792
    CrossrefPubMedGoogle Scholar
  • 21 Wolter J, Liehr H, Grun M. Hepatic clearance of endotoxins: differences in arterial and portal perfusion. J Ret Soc 1978; 03: 145-152
    PubMedGoogle Scholar
  • 22 Liehr H. Endotoxins and the pathogenesis of hepatic and gastrointestinal diseases. Adr Intern Med Pediatr 1982; 48: 117-193
    PubMedGoogle Scholar
  • 23 Semeraro N, Biondi A, Lorenzet R, Locati D, Mantovani A, Donati MB. Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites. Immunology 1983; 50: 529-535
    PubMedGoogle Scholar
  • 24 Colucci M, Balconi G, Lorenzet R, Pietra A, Locati PD. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71: 1893-1896
    CrossrefPubMedGoogle Scholar
  • 25 Devière J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, Dupont I. Excessive in vitro Lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 1990; 11: 628-634
    CrossrefPubMedGoogle Scholar
  • 26 Scarpati EM, Sadler SE. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem 1989; 264: 20705-20713
    PubMedGoogle Scholar
  • 27 Van Der Poll T, Buller HR, ten Cate H, Wortel CH, Baver KA, Van Deventer SJH, Hack CE, Saverwein HP, Rosenberg RD, Ten Cate JW. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990; 322: 1622-1627
    CrossrefPubMedGoogle Scholar